Medarex Reports Positive Results
Medarex Inc. (MEDX) reported positive trial data for its anthrax vaccine Valortim. The stock price surged $1.45 to close at $12.94.
posted by FC Market News at 2:17 PM
Friday, March 30, 2007
Previous Posts
- Magma Settles Dispute With Synopsys
- Revenue Falls Short For Global Payments
- ICT Slashes Outlook
- Earnings Double For Checkpoint Systems
- Approval Recommended For Dendreon's Provenge
- KMG's Rating Lowered
- Gol Linhas To Acquire Varig
- U. S. Steel To Acquire Lone Star
- Insituform Warns Of Lower Earnings
- Targeted Genetics Swings To Profit
0 Comments:
Post a Comment
<< Home